Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screening | Nature Communications
Cancer immunotherapy - Wikipedia
Engineering the perfect (bacterial) cancer therapy | Nature Reviews Cancer
Medicinal plants and bioactive natural compounds for cancer treatment: Important advances for drug discovery - ScienceDirect
Adverse drug reactions of anticancer drugs derived from natural sources - ScienceDirect
An analysis of genetic heterogeneity in untreated cancers | Nature Reviews Cancer
Forbes Publishes in Nature Reviews | College of Engineering | UMass Amherst
Interpreting pathways to discover cancer driver genes with Moonlight | Nature Communications
Cancers | Free Full-Text | Bioactive Compounds: Multi-Targeting Silver Bullets for Preventing and Treating Breast Cancer | HTML
The Gecko's Foot: Bio- Inspiration: Engineering New Materials from Nature: Forbes, Peter: 9780393337976: Amazon.com: Books
Bilateral murine tumor models for characterizing the response to immune checkpoint blockade.,Nature Protocols - X-MOL
Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma | Nature Communications
P53: The Gene That Cracked the Cancer Code by Sue Armstrong – review | Science and nature books | The Guardian
Metabolic profiling of cancer cells reveals genome-wide crosstalk between transcriptional regulators and metabolism | Nature Communications
Engineering the perfect (bacterial) cancer therapy | Nature Reviews Cancer
Cancer immunotherapy - Wikipedia
Cancer Research Meeting Offers Cambrian Explosion of Biology, Opportunity For Data Science
Frontiers | Progress in Neoantigen Targeted Cancer Immunotherapies | Cell and Developmental Biology
Frontiers | Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy | Cell and Developmental Biology
Detailed modeling of positive selection improves detection of cancer driver genes | Nature Communications
Breast cancer | Nature Reviews Disease Primers
Frontiers | PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer | Oncology
A New Cancer Treatment That Is Faster, More Efficient and Less Risky Is Coming: Bacteria Bombs - The New York Times
Salmonella-Mediated Cancer Therapy: An Innovative Therapeutic Strategy
An Orally Active Galectin-3 Antagonist Inhibits Lung Adenocarcinoma Growth and Augments Response to PD-L1 Blockade | Cancer Research
